Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

B cell Compartmentalization in Blood and Cerebrospinal Fluid of HIV- Infected Ugandans with Cryptococcal Meningitis.

Okurut S, Meya DB, Bwanga F, Olobo J, Eller MA, Cham-Jallow F, Bohjanen PR, Pratap H, Palmer BE, Hullsiek KH, Manabe YC, Boulware DR, Janoff EN.

Infect Immun. 2019 Dec 23. pii: IAI.00779-19. doi: 10.1128/IAI.00779-19. [Epub ahead of print]

2.

Public Health Laboratories: An Important Ally in Sexually Transmitted Infection Control.

Melendez JH, Manabe YC.

Sex Transm Dis. 2020 Feb;47(2):128-129. doi: 10.1097/OLQ.0000000000001118. No abstract available.

PMID:
31860553
3.

A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident TB and Mortality in Advanced HIV.

Manabe YC, Andrade BB, Gupte N, Leong S, Kintali M, Matoga M, Riviere C, Sameneka W, Lama JR, Naidoo K, Zhao Y, Johnson WE, Ellner JJ, Hosseinipour MC, Bisson GP, Salgame P, Gupta A; ACTG A5274 REMEMBER and NWCS 408 Study Team.

Clin Infect Dis. 2019 Nov 25. pii: ciz1147. doi: 10.1093/cid/ciz1147. [Epub ahead of print]

PMID:
31761933
4.

Bending the Arc towards Equitable Partnerships in Global Health and Applied Training.

Martin NA, Kalbarczyk A, Nagourney E, Reich A, Hansoti B, Kambugu A, Quinn TC, Manabe YC, Castelnuovo B.

Ann Glob Health. 2019 Nov 6;85(1):130. doi: 10.5334/aogh.2564.

5.

Empirical tuberculosis therapy in advanced HIV disease.

Manabe YC, Tenforde MW.

Lancet HIV. 2020 Jan;7(1):e3-e5. doi: 10.1016/S2352-3018(19)30327-3. Epub 2019 Nov 11. No abstract available.

PMID:
31727579
6.

Multicenter Study of the Accuracy of the BD MAX™ MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid.

Shah M, Paradis S, Betz J, Beylis N, Bharadwaj R, Caceres T, Gotuzzo E, Joloba M, Mave V, Nakiyingi L, Nicol MP, Pradhan N, King B, Armstrong D, Knecht D, Maus CE, Cooper CK, Dorman SE, Manabe YC.

Clin Infect Dis. 2019 Sep 27. pii: ciz932. doi: 10.1093/cid/ciz932. [Epub ahead of print]

PMID:
31560049
7.

Anti-retroviral therapy scale-up and its impact on sex-stratified tuberculosis notification trends in Uganda.

Zawedde-Muyanja S, Manabe YC, Musaazi J, Mugabe FR, Ross JM, Hermans S.

J Int AIDS Soc. 2019 Sep;22(9):e25394. doi: 10.1002/jia2.25394.

8.

A new vision for bioethics training in global health.

DeCamp M, Kalbarczyk A, Manabe YC, Sewankambo NK.

Lancet Glob Health. 2019 Aug;7(8):e1002-e1003. doi: 10.1016/S2214-109X(19)30273-6. No abstract available.

9.

Author Correction: The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2019 Jul 4;51(7):71. doi: 10.1038/s12276-019-0252-0.

10.

Change in Plasma Cryptococcal Antigen Titer Is Not Associated With Survival Among Human Immunodeficiency Virus-infected Persons Receiving Preemptive Therapy for Asymptomatic Cryptococcal Antigenemia.

Pullen MF, Kakooza F, Nalintya E, Kiragga AN, Morawski BM, Rajasingham R, Mubiru A, Manabe YC, Kaplan JE, Meya DB, Boulware DR.

Clin Infect Dis. 2020 Jan 2;70(2):353-355. doi: 10.1093/cid/ciz418. No abstract available.

PMID:
31119280
11.

Research Capacity Strengthening in Sub-Saharan Africa: Recognizing the Importance of Local Partnerships in Designing and Disseminating HIV Implementation Science to Reach the 90-90-90 Goals.

Kalbarczyk A, Davis W, Kalibala S, Geibel S, Yansaneh A, Martin NA, Weiss E, Kerrigan D, Manabe YC.

AIDS Behav. 2019 Sep;23(Suppl 2):206-213. doi: 10.1007/s10461-019-02538-0.

12.

Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda.

Musaazi J, Sekaggya-Wiltshire C, Kiragga AN, Kalule I, Reynolds SJ, Manabe YC, Castelnuovo B.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):514-521. doi: 10.5588/ijtld.18.0306.

PMID:
31064632
13.

Group Mentorship Model to Enhance the Efficiency and Productivity of PhD Research Training in Sub-Saharan Africa.

Manabe YC, Nambooze H, Okello ES, Kamya MR, Katabira ET, Ssinabulya I, Kaddumukasa M, Nabunnya Y, Bollinger RC, Sewankambo NK.

Ann Glob Health. 2018 Apr 30;84(1):170-175. doi: 10.29024/aogh.25.

14.

Implementation science: point-of-care diagnostics in HIV and tuberculosis.

Gupta-Wright A, Manabe YC.

Clin Med (Lond). 2019 Mar;19(2):145-148. doi: 10.7861/clinmedicine.19-2-145.

15.

Perspectives on male partner notification and treatment for syphilis among antenatal women and their partners in Kampala and Wakiso districts, Uganda.

Nakku-Joloba E, Kiguli J, Kayemba CN, Twimukye A, Mbazira JK, Parkes-Ratanshi R, Birungi M, Kyenkya J, Byamugisha J, Gaydos C, Manabe YC.

BMC Infect Dis. 2019 Feb 6;19(1):124. doi: 10.1186/s12879-019-3695-y.

16.

Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach.

Tenforde MW, Walker AS, Gibb DM, Manabe YC.

PLoS Med. 2019 Jan 15;16(1):e1002723. doi: 10.1371/journal.pmed.1002723. eCollection 2019 Jan.

17.

Defining System Requirements for Simplified Blood Culture to Enable Widespread Use in Resource-Limited Settings.

Dailey PJ, Osborn J, Ashley EA, Baron EJ, Dance DAB, Fusco D, Fanello C, Manabe YC, Mokomane M, Newton PN, Tessema B, Isaacs C, Dittrich S.

Diagnostics (Basel). 2019 Jan 11;9(1). pii: E10. doi: 10.3390/diagnostics9010010.

18.

Point-of-care diagnostics: needs of African health care workers and their role combating global antimicrobial resistance.

Parkes-Ratanshi R, Kikonyogo R, Hsieh YH, Nakku-Joloba E, Manabe YC, Gaydos CA, Rompalo A.

Int J STD AIDS. 2019 Mar;30(4):404-410. doi: 10.1177/0956462418807112. Epub 2019 Jan 9.

19.

Xpert® MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis.

Zawedde-Muyanja S, Manabe YC, Sewankambo NK, Nakiyingi L, Nakanjako D.

Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1475-1480. doi: 10.5588/ijtld.17.0460.

20.

Academic promotion policies and equity in global health collaborations.

Hedt-Gauthier B, Airhihenbuwa CO, Bawah AA, Burke KS, Cherian T, Connelly MT, Hibberd PL, Ivers LC, Jerome JG, Kateera F, Manabe YC, Maru D, Murray M, Shankar AH, Shuchman M, Volmink J.

Lancet. 2018 Nov 3;392(10158):1607-1609. doi: 10.1016/S0140-6736(18)32345-6. No abstract available.

PMID:
30496066
21.

Mentorship and Ethics in Global Health: Fostering Scientific Integrity and Responsible Conduct of Research.

Bukusi EA, Manabe YC, Zunt JR.

Am J Trop Med Hyg. 2019 Jan;100(1_Suppl):42-47. doi: 10.4269/ajtmh.18-0562.

22.

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.

Meya DB, Kiragga AN, Nalintya E, Morawski BM, Rajasingham R, Park BJ, Mubiru A, Kaplan JE, Manabe YC, Boulware DR.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):182-189. doi: 10.1097/QAI.0000000000001894.

23.

Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study.

Mabonga E, Parkes-Ratanshi R, Riedel S, Nabweyambo S, Mbabazi O, Taylor C, Gaydos C, Manabe YC.

Int J STD AIDS. 2019 Mar;30(3):256-263. doi: 10.1177/0956462418799017. Epub 2018 Nov 4.

24.

Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Burnett SM, Zawedde-Muyanja S, Hermans SM, Weaver MR, Colebunders R, Manabe YC.

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):605-611. doi: 10.1097/QAI.0000000000001862.

25.

Infectious Diseases Physicians: Improving and Protecting the Public's Health: Why Equitable Compensation Is Critical.

Zahn M, Adalja AA, Auwaerter PG, Edelson PJ, Hansen GR, Hynes NA, Jezek A, MacArthur RD, Manabe YC, McGoodwin C, Duchin JS.

Clin Infect Dis. 2019 Jul 2;69(2):352-356. doi: 10.1093/cid/ciy888.

PMID:
30329044
26.

Brief Report: Pulmonary Tuberculosis Is Associated With Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Coinfected Ugandans.

Olson A, Ragan EJ, Nakiyingi L, Lin N, Jacobson KR, Ellner JJ, Manabe YC, Sagar M.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):407-411. doi: 10.1097/QAI.0000000000001823.

27.

Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.

Worodria W, Ssempijja V, Hanrahan C, Ssegonja R, Muhofwa A, Mazapkwe D, Mayanja-Kizza H, Reynolds SJ, Colebunders R, Manabe YC.

AIDS. 2018 Sep 24;32(15):2141-2149. doi: 10.1097/QAD.0000000000001941.

28.

Challenges of Rapid Plasma Reagin Interpretation in Syphilis Screening in Uganda: Variability in Nontreponemal Results Between Different Laboratories.

Hamill MM, Mbazira KJ, Kiragga AN, Gaydos CA, Jett-Goheen M, Parkes-Ratanshi R, Manabe YC, Nakku-Joloba E, Rompalo A.

Sex Transm Dis. 2018 Dec;45(12):829-833. doi: 10.1097/OLQ.0000000000000883.

29.

The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2018 May 22;50(5):66. doi: 10.1038/s12276-018-0094-1. Review. Erratum in: Exp Mol Med. 2019 Jul 4;51(7):71.

30.

"Tuberculosis in advanced HIV infection is associated with increased expression of IFNγ and its downstream targets".

Verma S, Du P, Nakanjako D, Hermans S, Briggs J, Nakiyingi L, Ellner JJ, Manabe YC, Salgame P.

BMC Infect Dis. 2018 May 15;18(1):220. doi: 10.1186/s12879-018-3127-4.

31.

Vector-Borne Disease is a Common Cause of Hospitalized Febrile Illness in India.

Robinson ML, Kadam D, Khadse S, Balasubramanian U, Raichur P, Valvi C, Marbaniang I, Kanade S, Sachs J, Basavaraj A, Bharadwaj R, Kagal A, Kulkarni V, Zenilman J, Nelson G, Manabe YC, Kinikar A, Gupta A, Mave V.

Am J Trop Med Hyg. 2018 May;98(5):1526-1533. doi: 10.4269/ajtmh.17-0571. Epub 2018 Mar 22.

32.

The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs.

Sekaggya-Wiltshire C, Lamorde M, Kiragga AN, Dooley KE, Kamya MR, Kambugu A, Fehr J, Manabe YC, Castelnuovo B.

Tuberculosis (Edinb). 2018 Jan;108:77-82. doi: 10.1016/j.tube.2017.11.004. Epub 2017 Nov 7. Review.

33.

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.

34.

Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda.

Nakiyingi L, Nakanwagi P, Briggs J, Agaba T, Mubiru F, Mugenyi M, Ssengooba W, Joloba ML, Manabe YC.

BMC Infect Dis. 2018 Feb 21;18(1):87. doi: 10.1186/s12879-018-2992-1.

35.

Synergistic Impact of Training Followed by On-Site Support on HIV Clinical Practice: A Mixed-Design Study in Uganda With Pre/Post and Cluster-Randomized Trial Components.

Burnett SM, Mubiru N, Imani P, Mbonye MK, Fisher L, Colebunders R, Manabe YC, Weaver MR.

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):467-475. doi: 10.1097/QAI.0000000000001630.

PMID:
29346184
36.

Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda.

Kajumbula H, Fujita AW, Mbabazi O, Najjuka C, Izale C, Akampurira A, Aisu S, Lamorde M, Walwema R, Bahr NC, Meya DB, Boulware DR, Manabe YC.

Emerg Infect Dis. 2018 Jan;24(1):174-175. doi: 10.3201/eid2401.171112.

37.

Antimicrobial Resistance of Sterile Site Infections in Sub-Saharan Africa: A Systematic Review.

Workneh M, Katz MJ, Lamorde M, Cosgrove SE, Manabe YC.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx209. doi: 10.1093/ofid/ofx209. eCollection 2017 Fall.

38.

Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda.

Hermans SM, Elbireer S, Tibakabikoba H, Hoefman BJ, Manabe YC.

Patient Prefer Adherence. 2017 Aug 31;11:1479-1487. doi: 10.2147/PPA.S135540. eCollection 2017.

39.

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Siegel M, Manabe YC, Frank I, Ho K, Santana J, Stekler JD, Swaminathan S, McCauley M, Hodder S, Mayer KH.

Ann Intern Med. 2017 Sep 19;167(6):384-393. doi: 10.7326/M17-0520. Epub 2017 Aug 22.

40.

Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.

Bisson GP, Ramchandani R, Miyahara S, Mngqibisa R, Matoga M, Ngongondo M, Samaneka W, Koech L, Naidoo K, Rassool M, Kirui F, Banda P, Mave V, Kadam D, Leger P, Henestroza G, Manabe YC, Bao J, Kumwenda J, Gupta A, Hosseinipour MC; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

AIDS. 2017 Oct 23;31(16):2217-2225. doi: 10.1097/QAD.0000000000001606.

41.

Reducing Uncertainty for Acute Febrile Illness in Resource-Limited Settings: The Current Diagnostic Landscape.

Robinson ML, Manabe YC.

Am J Trop Med Hyg. 2017 Jun;96(6):1285-1295. doi: 10.4269/ajtmh.16-0667. Review.

42.

Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.

Hermans SM, Babirye JA, Mbabazi O, Kakooza F, Colebunders R, Castelnuovo B, Sekaggya-Wiltshire C, Parkes-Ratanshi R, Manabe YC.

BMC Infect Dis. 2017 Jun 16;17(1):433. doi: 10.1186/s12879-017-2534-2.

43.

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.

Montgomery MP, Nakasujja N, Morawski BM, Rajasingham R, Rhein J, Nalintya E, Williams DA, Huppler Hullsiek K, Kiragga A, Rolfes MA, Donahue Carlson R, Bahr NC, Birkenkamp KE, Manabe YC, Bohjanen PR, Kaplan JE, Kambugu A, Meya DB, Boulware DR; COAT and ORCAS Trial Teams.

BMC Neurol. 2017 Jun 12;17(1):110. doi: 10.1186/s12883-017-0878-2.

44.

Immune Reconstitution Inflammatory Syndrome (IRIS): What pathologists should know.

Nelson AM, Manabe YC, Lucas SB.

Semin Diagn Pathol. 2017 Jul;34(4):340-351. doi: 10.1053/j.semdp.2017.04.010. Epub 2017 Apr 26. Review.

PMID:
28552210
45.

Premature Coronary Artery Disease and ST-Elevation Myocardial Infarction in a 24-Year-Old Man With Perinatally Acquired Human Immunodeficiency Virus: A Case Report.

Griffith DC, Aronis KN, Orozco AM, Traill TA, Manabe YC, Agwu AL.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofw260. doi: 10.1093/ofid/ofw260. eCollection 2017 Winter.

46.

Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.

Sekaggya-Wiltshire C, von Braun A, Scherrer AU, Manabe YC, Buzibye A, Muller D, Ledergerber B, Gutteck U, Corti N, Kambugu A, Byakika-Kibwika P, Lamorde M, Castelnuovo B, Fehr J, Kamya MR.

J Antimicrob Chemother. 2017 Apr 1;72(4):1172-1177. doi: 10.1093/jac/dkw534.

47.

Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.

Manabe YC, Worodria W, van Leth F, Mayanja-Kizza H, Traore AN, Ferro J, Pakker N, Frank M, Grobusch MP, Colebunders R, Cobelens F.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1265-1271. Epub 2016 Oct 17.

48.
49.

Effect of On-Site Support on Laboratory Practice for Human Immunodeficiency Virus, Tuberculosis, and Malaria Testing.

Burnett SM, Mbonye MK, Martin R, Ronald A, Zawedde-Muyanja S, Willis KS, Colebunders R, Manabe YC, Weaver MR.

Am J Clin Pathol. 2016 Oct;146(4):469-77. doi: 10.1093/ajcp/aqw138.

PMID:
27686173
50.

Training tomorrow's leaders in global health: impact of the Afya Bora Consortium Fellowship on the careers of its alumni.

Monroe-Wise A, Mashalla Y, O'Malley G, Nathanson N, Seloilwe E, Gachuno O, Odero T, Nakanjako D, Sewankambo N, Tarimo E, Urassa D, Manabe YC, Chapman S, Voss JG, Wasserheit J, Farquhar C; Afya Bora Consortium Working Group.

BMC Med Educ. 2016 Sep 19;16(1):241. doi: 10.1186/s12909-016-0750-x.

Supplemental Content

Loading ...
Support Center